What is DA Davidson’s Estimate for Cognex FY2025 Earnings?

Cognex Corporation (NASDAQ:CGNX) – Investment analysts at DA Davidson lifted their FY2025 EPS estimates for Cognex in a research note issued to investors on Tuesday, November 4th. DA Davidson analyst M. Summerville now expects that the scientific and technical instruments company will post earnings of $0.73 per share for the year, up from their previous estimate of $0.66. DA Davidson currently has a “Neutral” rating and a $38.00 target price on the stock. The consensus estimate for Cognex’s current full-year earnings is $0.61 per share. DA Davidson also issued estimates for Cognex’s FY2026 earnings at $0.83 EPS.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.06. Cognex had a net margin of 11.33% and a return on equity of 8.26%. The company had revenue of $276.89 million during the quarter, compared to the consensus estimate of $261.86 million. During the same quarter in the previous year, the company posted $0.20 earnings per share. The company’s revenue for the quarter was up 18.0% compared to the same quarter last year. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS.

Several other equities research analysts also recently weighed in on CGNX. The Goldman Sachs Group upped their price objective on shares of Cognex from $36.00 to $40.00 and gave the stock a “sell” rating in a report on Tuesday, September 16th. Needham & Company LLC upped their price objective on shares of Cognex from $45.00 to $47.00 and gave the stock a “buy” rating in a report on Friday, October 31st. KeyCorp reaffirmed an “overweight” rating and issued a $50.00 price objective on shares of Cognex in a report on Friday, October 31st. Melius raised shares of Cognex from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a report on Thursday, July 10th. Finally, Barclays reaffirmed an “overweight” rating and issued a $56.00 price objective (up previously from $55.00) on shares of Cognex in a report on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $46.20.

Cognex Stock Performance

Shares of CGNX opened at $40.50 on Thursday. Cognex has a 1 year low of $22.67 and a 1 year high of $49.76. The company has a market cap of $6.79 billion, a price-to-earnings ratio of 63.28 and a beta of 1.52. The firm has a fifty day moving average of $45.10 and a 200-day moving average of $37.41.

Cognex Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 28th. Stockholders of record on Thursday, November 13th will be issued a $0.085 dividend. The ex-dividend date is Thursday, November 13th. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.8%. This is a positive change from Cognex’s previous quarterly dividend of $0.08. Cognex’s dividend payout ratio is currently 53.13%.

Insider Transactions at Cognex

In other news, Director Robert Willett sold 6,704 shares of the company’s stock in a transaction dated Tuesday, October 21st. The stock was sold at an average price of $49.51, for a total value of $331,915.04. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Sheila Marie Dipalma sold 2,002 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $45.00, for a total value of $90,090.00. Following the completion of the transaction, the executive vice president owned 8,582 shares in the company, valued at $386,190. This represents a 18.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 10,706 shares of company stock worth $512,065 in the last quarter. 1.60% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Cognex

A number of large investors have recently added to or reduced their stakes in the stock. Quent Capital LLC bought a new stake in shares of Cognex in the third quarter valued at approximately $26,000. REAP Financial Group LLC bought a new stake in shares of Cognex in the third quarter valued at approximately $27,000. Geneos Wealth Management Inc. boosted its position in shares of Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 736 shares during the period. Penserra Capital Management LLC bought a new stake in shares of Cognex in the second quarter valued at approximately $29,000. Finally, TD Waterhouse Canada Inc. bought a new stake in shares of Cognex in the second quarter valued at approximately $29,000. Institutional investors own 88.12% of the company’s stock.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.